Avicanna Inc (AVCN : TSX)
Common Stock
Follow AVCN
AVCN
Avicanna Inc
Performance
1 Day
+17.65%
1 Week
-4.76%
1 Month
+0.00%
YTD
-54.55%
The Tuesday Stock Pick · free, every tuesday morning. One Canadian stock and the case for it.
Key Statistics
Market Cap
$13.44M
52W High
$0.28
52W Low
$0.08
P/E Ratio
-
50 Day MA
$0.11
200 Day MA
$0.14
Beta
0.35
Dividend Yield
-
Performance history
AVCN returns since 2023
Avicanna Inc has traded since Nov 2023 in our data, with 0 up years out of 2 full calendar years. Its deepest fall was −85.1% (Mar 2024 to Nov 2026).
1 year / yr
−63.0%
3 years / yr
−36.7%
5 years / yr
—
10 years / yr
—
Calendar-year returns
- 2023*−14.6%
- 2024−12.9%
- 2025−26.2%
- 2026*−55.6%
* Partial year (first year of data, or year to date).
$10,000 invested in AVCN
- 1 year ago$3,704
- 2023 (start of our data)$2,439
- Best year
- 2024: −12.9%
- Worst year
- 2025: −26.2%
- All-time high in our data
- $1 on Mar 18, 2024 · now −82.5%
Total-return basis using adjusted daily closes from the Toronto Stock Exchange and TSX Venture (dividends and splits folded in), Nov 2023 to Nov 2026. Past returns do not predict future ones.
Earnings
AVCN earnings history
Avicanna Inc's reported EPS by quarter.
| Quarter ending | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 30, 2026 | Aug 13, 2026 | −$0.01 | — | — |
| Mar 31, 2026 | May 13, 2026 | −$0.01 | — | — |
| Sep 30, 2025 | Nov 13, 2025 | −$0.01 | — | — |
| Jun 30, 2025 | Aug 14, 2025 | −$0.01 | — | — |
| Mar 31, 2025 | May 14, 2025 | $0.00 | — | — |
| Sep 30, 2024 | Nov 14, 2024 | −$0.01 | — | — |
| Jun 30, 2024 | Aug 14, 2024 | −$0.02 | — | — |
| Mar 31, 2024 | May 13, 2024 | −$0.03 | — | — |
EPS as reported vs consensus estimate. TSX earnings calendar →
Awesome Portfolio™
Looking past AVCN? Our 10 best Canadian stocks, in one list.
14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 11/13/2026 | $0.09 | $0.10 | $0.09 | $0.10 | $0.10 | 110,510 |
| 11/12/2026 | $0.09 | $0.09 | $0.09 | $0.09 | $0.09 | 39,037 |
| 11/11/2026 | $0.10 | $0.10 | $0.08 | $0.09 | $0.09 | 4,125,201 |
| 11/10/2026 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | 564,250 |
| 11/9/2026 | $0.11 | $0.11 | $0.10 | $0.10 | $0.10 | 31,511 |
| 11/6/2026 | $0.10 | $0.10 | $0.10 | $0.10 | $0.10 | 107,800 |
| 11/5/2026 | $0.11 | $0.11 | $0.10 | $0.10 | $0.10 | 100,500 |
| 11/4/2026 | $0.11 | $0.12 | $0.11 | $0.11 | $0.11 | 11,510 |
| 11/3/2026 | $0.12 | $0.12 | $0.11 | $0.11 | $0.11 | 23,249 |
| 11/2/2026 | $0.11 | $0.11 | $0.10 | $0.10 | $0.10 | 34,575 |
Analyst Price Targets
Based on analyst covering AVCN · as of Sep 17, 2026
Wall Street analysts forecast AVCN stock price to rise 600.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.70
+600.0% Upside
Current Price
C$0.10
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AVCN's historical volatility
30-Day Vol
103.5%
Annualized
90-Day Vol
87.9%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.08
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.09 | C$0.07 – C$0.13 |
| 60 trading days | C$0.09 | C$0.05 – C$0.15 |
| 90 trading days | C$0.08 | C$0.05 – C$0.16 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Avicanna Inc
Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for medical and pharmaceutical markets in Canada and internationally. It provides medical cannabis formulary products, including oral, sublingual, topical, and transdermal deliveries with various ratios of cannabinoids under the RHO Phyto brand; and indication-specific cannabinoid-based candidates to address unmet medical needs in the areas of dermatology, chronic pain, and various neurological disorders, as well as Trunerox, an indication-specific drug treatment for seizure associated with Lennox-Gastaut Syndrome and Dravet Syndrome. The company also offers active pharmaceutical ingredients comprising various cannabidiol, tetrahydrocannabinol, and cannabigerol for use in the development and production of food, cosmetics, medical, and pharmaceutical products under the Aureus Santa Marta brand. In addition, it operates MyMedi.ca, a medical cannabis care platform that offers a diverse portfolio of products and bilingual pharmacist-led patient support programs, specialty services to veterans, as well as provides educational resources to the medical community to facilitate the incorporation of medical cannabis into health care regimens; and collaborates with public and private payers for adjudication and reimbursement. The company has a research and collaboration agreement with a multinational European based pharmaceutical company to assess its proprietary SEDDS technology in combination with Collaborator's various drug delivery and pharmaceutical formats. Avicanna Inc. was incorporated in 2016 and is headquartered in Toronto, Canada.
Financials
- Revenue (TTM)
- $25.31M
- EBITDA
- $-3.11M
- Profit Margin
- -14.75%
- ROE (TTM)
- -30.04%
- EPS (Diluted)
- -0.03
- Book Value
- 0.02
Classification
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Free newsletter
The Tuesday Stock Pick
One Canadian stock and the case for it
- The name with the biggest gap to analyst targets
- The chart, insider buying and what is driving it
- A plain-English bottom line, no hype
Explore More
Common Questions About AVCN
Market movers
Recent TSX movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| BYL | Baylin Technologies Inc | $0.14 | +40.00% |
| ANRG | Anaergia Inc | $2.14 | +16.94% |
| STN | Stantec Inc | $122.20 | +13.79% |
| HWO | High Arctic Energy Services Inc. | $1.34 | +13.56% |
| MRE | Martinrea International Inc. | $10.95 | +13.35% |
| GRA | NanoXplore Inc | $1.61 | +11.03% |
| GMIN | G Mining Ventures Corp. | $46.21 | +9.89% |
| KEL | Kelt Exploration Ltd. | $11.49 | +8.81% |
Free with a Wealth Awesome account
Keep analysing AVCN, free
- Every WA Score, ranking and table
- Insider track records and SEDI filings
- Earnings history and analyst targets for every stock
Email only, no password, no card. Already a member? Use the same button to sign in.
